CUSIP H17182108NAMEN AKTCRSPQ4 2025
44 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ark Investment Management LLC | 10.52M | $551.78M |
| 2 | Blackrock, Inc. | 7.51M | $393.73M |
| 3 | Orbis Allan Gray Ltd | 5.95M | $312.03M |
| 4 | Capital International Investors | 5.89M | $309.02M |
| 5 | State Street Corp | 3.75M | $196.83M |
| 6 | Gsk PLC | 3.22M | $168.89M |
| 7 | Ubs Group AG | 2.52M | $132.37M |
| 8 | Vanguard Group Inc | 2.27M | $118.95M |
| 9 | Geode Capital Management, LLC |
| 4 | Nov 4, 2025 | Ark Investment Management LLC | 13G/A | 10.8% | 9.79M | SEC |
| 5 | Jul 17, 2025 | Blackrock, Inc. | 13G | 6.9% | 5.93M | SEC |
| 6 | May 14, 2025 | Ark Investment Management LLC | 13G/A | 11.8% | 10.17M | SEC |
| 7 | May 13, 2025 | Capital International Investors | 13G/A | 7.4% | 6.33M | SEC |
| 8 | Feb 14, 2025 | Ark Investment Management LLC | 13G/A | 10.5% | 8.97M | SEC |
| 9 | Jan 10, 2025 | Ark Investment Management LLC | 13G/A | 8.8% | 7.50M | SEC |
| 10 | Dec 10, 2024 | Ark Investment Management LLC | 13G/A | 10.7% | 9.12M | SEC |
See the full Schedule 13D/13G history for Crispr Therapeutics AG.
Unlock full history| 2.25M |
| $117.97M |
| 10 | Sr One Capital Management, LP | 2.04M | $106.91M |